Just started my tren ace.. 40mgs of test and 40 of tren. Starting slow and EOD injections.
Will prolly do higher tren than test. 150 test and 200 tren PW
Sent from my SM-G950F using Tapatalk
I'm talking at least 2 parts tren with 1 part test, at the very least.
So i decided to drop the tren as of now... I will start the Mk677 and wait till NPP arrives...
Or i might just do eod injections with tren
Might just start a new thread
Sent from my SM-G950F using Tapatalk
Here is a chart from a pubmed.com study showing HGH and IGF1 output after 6 months and 1 year of 25mg MK-677 use. There is also the HGH pulses taken from blood draws around the clock showing the peaks of the pulses from one dose of MK-677. Science shows the benefits continue after one year of non stop use. The highest HGH pulse of approximately 14 hours after oral administration.
Here is a chart from a pubmed.com study showing HGH and IGF1 output after 6 months and 1 year of 25mg MK-677 use. There is also the HGH pulses taken from blood draws around the clock showing the peaks of the pulses from one dose of MK-677. Science shows the benefits continue after one year of non stop use. The highest HGH pulse of approximately 14 hours after oral administration.
I would like to know the studies after 1 month use. But im to lazy to look it up
Definitely getting leaner and can see the cuts. Its been so damn hot that I been sweating balls 20 mins of my workout, so no need for cardio...
Dropped the carbs to 100 and increase my fats between 70-80.. protein is high...
Dropped drol..
Only doing prop and achemsTest E
25mgs proviron
4 more weeks till diet till I fuck it up.again in Egypt
I would like to know the studies after 1 month use. But im to lazy to look it up
Sent from my SM-G950F using Tapatalk
This study is 2 weeks of MK-677 while calorie restricted.
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
Randomized controlled trial
Murphy MG, et al. J Clin Endocrinol Metab. 1998.
Abstract
The reversal of diet-induced negative nitrogen balance by GH suggests a possible therapeutic role for GH treatment in catabolic patients. A double-blind, randomized, placebo-controlled, two-period cross-over study was designed to investigate whether MK-677, an orally active nonpeptide mimic of GH-releasing peptide, can reverse diet-induced protein catabolism. Eight healthy volunteers (ages 24-39 yr) were calorically restricted (18 kcal/kg.day) for two 14-day periods. During the last 7 days of each diet period, subjects received either oral MK-677 25 mg or placebo once daily. There was a 14- to 21-day washout interval between periods. During the first week of caloric restriction (i.e. diet alone), daily nitrogen losses were similar for both treatment groups (mean +/- SE; MK-677 group -2.67 +/- 0.40 g/day vs. placebo group -2.83 +/- 0.26 g/day). During the second week (diet and study drug), mean daily nitrogen balance was 0.31 +/- 0.21 g/day in the MK-677 treatment group compared with -1.48 +/- 0.21 g/day in the placebo group (P < 0.01). MK-677 improved nitrogen balance integrated over the 7 days of treatment; area under the curve day 8-14 nitrogen balance response was +2.69 +/- 5.0 (SE) for MK-677 and -8.97 +/- 5.26 g.day for placebo (P < 0.001). MK-677 produced a peak GH response of 55.9 +/- 31.7 micrograms/L after single dose (day 1 of treatment) and 22.6 +/- 9.3 micrograms/L after a week of dosing compared with placebo treatment peak GH values of approximately 9 (treatment day 1) and approximately 7 micrograms/L (treatment day 7). Following the initial 7-day caloric restriction, insulin-like growth factor-I (IGF-I) declined from 232 +/- 25 to 186 +/- 19 ng/mL in the MK-677 group and from 236 +/- 19 to 174 +/- 23 ng/mL in the placebo group. Mean IGF-I concentration increased significantly during MK-677 to 264 +/- 31 ng/mL (mean for the last 5 days of treatment) compared with 188 +/- 19 ng/mL with placebo (P < 0.01). No significant difference in IGF binding protein-2 was found between the MK-677 and placebo treatments. However, the mean in IGF binding protein-3 for the last 5 days of MK-677 treatment was also significantly increased to 3273 +/- 330 ng/mL (mean +/- SE) compared with placebo 2604 +/- 253 ng/mL (P < 0.01). Neither the serum cortisol nor the PRL response was significantly greater after 7 days of MK-677 dosing compared with 7 days of placebo. MK-677 (25 mg) was generally well tolerated and without clinically significant adverse experiences. In conclusion, MK-677 reverses diet-induced nitrogen wasting, suggesting that if these short-term anabolic effects are maintained in patients who are catabolic because of certain acute or chronic disease states, it may be useful in treating catabolic conditions.
Just ordered some mcdonalds cause im about to pop this mk677. Just in case i get a massive hunger spike. I don't think clean food will cut it on this. We will see.. will take 10mgs.
Burger, fries and a big ass muffin[emoji2]
Keep in mind i have taking mk677 in the past, but was very inconsistent with it. So i can not say i had any benefits besides aleep and hunger
Comment